Pulmonology billing breaks in five places at once. A single patient visit for a new asthma diagnosis generates PFT codes that trigger CCI bundling edits, a bronchodilator response test that replaces (not supplements) the base spirometry code, an E/M with a modifier -25 for the separate evaluation, and potentially a biologic initiation that launches a multi-year buy-and-bill cycle with payer-mandated step therapy documentation. A bronchoscopy session the following week adds 4–8 procedure codes with hierarchy rules that bundle the diagnostic base into every interventional code. And when that same patient shows up in the ICU three months later with a COPD exacerbation, the practice now bills critical care time that must be documented to the minute — alongside ventilator management codes that have their own daily billing rules.
The financial exposure is real. Pulmonology practices with 3–8 providers lose $200K–$500K annually to PFT coding errors and bundling violations, bronchoscopy hierarchy mistakes, biologics buy-and-bill gaps, critical care documentation failures, and sleep study billing oversights. With the industry-wide denial rate at 9% and AR days averaging 42 (AMS Solutions 2026), and billing staff turnover running 30–40% (HFMA 2026), manual teams cannot manage the five distinct billing workflows that converge in a pulmonology practice.
AI agents built for pulmonology billing eliminate every category of that leakage. Here's exactly how.
Pulmonary Function Testing: The Bundling Minefield That Costs $40K–$100K Per Year
PFTs are the diagnostic backbone of pulmonology — and the most error-prone billing category in the specialty. A comprehensive PFT session involves multiple individual tests, each with its own CPT code, but the codes interact through Correct Coding Initiative (CCI) bundling edits that make independent billing of certain combinations a compliance violation.
The PFT Code Landscape
- 94010 — Spirometry (basic, no bronchodilator)
- 94060 — Spirometry with bronchodilator response (pre- and post-bronchodilator; includes 94010)
- 94729 — Diffusing capacity (DLCO)
- 94726 — Lung volumes by plethysmography (body box)
- 94727 — Lung volumes by gas dilution (helium dilution or nitrogen washout)
- 94200 — Maximum voluntary ventilation (MVV)
- 94070 — Bronchial challenge testing (methacholine, mannitol)
- 94375 — Respiratory flow-volume loop
- 94618 — Pulmonary stress testing (cardiopulmonary exercise test, CPET)
The most expensive billing error in PFT coding: billing 94010 (spirometry) alongside 94060 (bronchodilator response). Code 94060 includes pre-bronchodilator spirometry by definition — it is the complete pre- and post-bronchodilator assessment. When a billing team submits both codes for the same session, the claim either triggers an automatic CCI denial or, worse, pays on both codes and triggers a retrospective audit with recoupment of the 94010 payment plus a compliance flag.
The second failure pattern: billing 94726 (plethysmography lung volumes) and 94727 (gas dilution lung volumes) together. These are mutually exclusive measurement methodologies — a lab performs one or the other per session, not both. Submitting both generates an immediate denial. But billing teams that process PFT orders without understanding the clinical distinction between these tests sometimes bill whichever code appears first in their charge master.
The charge capture gap runs the other direction too. A physician orders "complete PFTs" and the lab performs spirometry with bronchodilator response, DLCO, plethysmography lung volumes, and MVV. The billing team captures the spirometry (94060) and DLCO (94729) but misses lung volumes (94726) and MVV (94200) — dropping $80–$120 per session across thousands of annual PFTs.
What AI agents do: AI reads the PFT lab report and maps every performed test to its CPT code — then validates the code set against CCI edits before submission. AI blocks the 94010 + 94060 dual billing, prevents 94726 + 94727 same-session conflicts, ensures every performed test is captured (including MVV and flow-volume loops that manual teams frequently miss), and pairs each test with the required physician interpretation. AI also validates that the ordering diagnosis supports medical necessity for each component — DLCO requires a clinical indication beyond screening spirometry, and bronchial challenge testing (94070) requires documented diagnostic uncertainty between asthma and other conditions. For practices performing 2,000–5,000 PFT sessions annually, correct code selection and bundling compliance recovers $40K–$100K.
Bronchoscopy: The Procedure Hierarchy Where Every Add-On Code Matters
Bronchoscopy is the interventional core of pulmonology — and the procedure category where CPT hierarchy rules create the most billing complexity. A single bronchoscopy session can involve 4–8 distinct procedures across different bronchial segments, each coded separately but subject to hierarchy rules that determine which codes can be billed together.
Bronchoscopy Code Hierarchy
- 31622 — Diagnostic bronchoscopy (bundled into ALL interventional bronchoscopy codes)
- 31623 — With brushing or protected brushings
- 31624 — With bronchoalveolar lavage (BAL)
- 31625 — With bronchial biopsy (single or multiple)
- 31628 — With transbronchial lung biopsy, single lobe
- 31629 — With transbronchial lung biopsy, each additional lobe (add-on to 31628)
- 31652 — EBUS-TBNA, first two lymph node stations
- 31653 — EBUS-TBNA, each additional lymph node station (add-on to 31652)
- 31627 — Computer-assisted navigational bronchoscopy (add-on)
- 31636/31637 — Bronchial stent placement / each additional
- 31634 — Balloon dilation of bronchus
- 31645/31646 — Therapeutic aspiration, initial / subsequent
The critical rule: diagnostic bronchoscopy (31622) is included in every interventional bronchoscopy code. It can never be billed separately when any interventional procedure is performed during the same session. Billing teams that submit 31622 alongside 31625 or 31628 generate CCI denials and audit flags.
The underbilling pattern is equally costly. A pulmonologist performs an EBUS-TBNA sampling three lymph node stations (31652 + 31653), then performs a transbronchial biopsy of a parenchymal lesion in the right lower lobe (31628), followed by BAL of the lingula for infection workup (31624). The billing team captures the EBUS codes but misses the transbronchial biopsy and BAL — because the procedure note describes them as part of a single bronchoscopy session, and the coder doesn't realize each anatomically distinct procedure is separately reportable with modifier -59 or -XS.
Navigational bronchoscopy (31627) creates another capture gap. This is an add-on code reported alongside the primary procedure code when electromagnetic navigation or virtual bronchoscopy guidance is used for the procedure. Practices that invested $150K–$300K in superDimension, Ion, or Monarch robotic platforms sometimes fail to capture the navigation add-on code on every case — leaving $300–$500 per procedure on the table.
What AI agents do: AI reads the bronchoscopy procedure note and maps every performed procedure to its CPT code — then validates the complete code set against hierarchy and bundling rules. AI blocks diagnostic 31622 from billing alongside any interventional code, applies modifier -59/-XS when distinct anatomic sites justify separate procedure billing, captures navigational bronchoscopy add-on (31627) on every case where navigation technology was documented, ensures EBUS add-on stations (31653) are counted correctly against the documented lymph node map, and pairs procedure codes with the appropriate sedation codes (99151–99153 for moderate sedation, or coordinates with anesthesia for deep sedation 00520). For practices performing 300–800 bronchoscopies annually, complete hierarchy validation and add-on capture recovers $50K–$120K.
Biologics for Severe Asthma and COPD: The Buy-and-Bill Cycle That Runs for Years
The biologic revolution in pulmonology has created a new revenue stream — and a new billing complexity layer. Five FDA-approved biologics for severe asthma, with dupilumab also approved for COPD, each carry per-dose costs of $1,500–$3,500 and require payer-mandated step therapy documentation, phenotype-specific prescribing criteria, and ongoing prior authorization renewals that span multi-year treatment courses.
Biologic Agents and Coding
- Omalizumab (Xolair) — J2357, dosed by weight and IgE level, 150–375 mg every 2–4 weeks, allergic asthma with IgE 30–1,500 IU/mL
- Mepolizumab (Nucala) — J2182, 100 mg SC every 4 weeks, eosinophilic asthma with eosinophils ≥150 cells/μL
- Benralizumab (Fasenra) — J0517, 30 mg SC every 4 weeks × 3 then every 8 weeks, eosinophilic asthma with eosinophils ≥150 cells/μL
- Dupilumab (Dupixent) — J0593, 200 mg or 300 mg SC every 2 weeks, eosinophilic/OCS-dependent asthma and moderate-to-severe COPD with type 2 inflammation
- Tezepelumab (Tezspire) — J2356, 210 mg SC every 4 weeks, severe asthma regardless of phenotype (broadest indication)
The step therapy trap: every major payer requires documented failure on high-dose inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) combination therapy before approving a biologic. Some payers add additional steps — trial of tiotropium (Spiriva), trial of leukotriene receptor antagonist (montelukast), or documented oral corticosteroid dependence. If the step therapy documentation isn't captured in the prior authorization request with specific dates, doses, and documented treatment failure, the biologic authorization is denied — often after the practice has already purchased and administered the first dose at $1,500–$3,500 out of pocket.
The dosing complexity adds another failure point. Omalizumab dosing is uniquely complex — determined by a matrix of patient weight (30–150+ kg) and total serum IgE level (30–1,500 IU/mL) that produces doses ranging from 150 mg to 375 mg administered every 2 or 4 weeks. A weight change of 5 kg or an IgE recheck can shift the dose and schedule, changing the billed units. Benralizumab has a loading-dose phase (every 4 weeks for 3 doses) before transitioning to maintenance dosing (every 8 weeks) — billing the maintenance schedule during the loading phase or vice versa triggers denials.
What AI agents do: AI manages the complete biologics lifecycle — from step therapy documentation through ongoing buy-and-bill. Before the first dose, AI verifies that all payer-required step therapy has been documented (ICS/LABA failure dates, additional controller trial periods, exacerbation history, blood eosinophil and IgE levels), submits the prior authorization with structured clinical evidence, and tracks approval status. For each administration visit, AI selects the correct J-code, calculates dosing units based on the patient's current weight and phenotype markers, captures drug waste with -JW on partially used vials, pairs the drug code with the correct administration code (96372 SC injection), and reconciles acquisition cost against reimbursement. AI tracks benralizumab's loading-to-maintenance transition automatically, recalculates omalizumab doses when weight or IgE changes, and initiates prior authorization renewal 3–4 weeks before expiration. For practices administering biologics to 100–400 patients, correct buy-and-bill management recovers $40K–$100K annually.
Critical Care and Ventilator Management: The Documentation-Driven Revenue at Risk
Pulmonary/critical care medicine — the dual subspecialty that defines most academic and large-group pulmonology practices — generates its highest per-encounter revenue from critical care and ventilator management billing. But these are the most documentation-sensitive codes in the entire CPT system.
Critical Care and Ventilator Codes
- 99291 — Critical care, first 30–74 minutes (requires total critical care time documentation)
- 99292 — Each additional 30 minutes (add-on to 99291)
- 94002 — Ventilator management, initial day (hospital inpatient)
- 94003 — Ventilator management, subsequent day (hospital inpatient)
- 94004 — Ventilator management, nursing facility
- 94005 — Home ventilator management
- 31500 — Endotracheal intubation (separately reportable from critical care)
The critical care documentation requirement is absolute: the physician must document total time spent in critical care activities — not bedside time, not rounding time, but time spent in activities that directly contribute to the management of the critically ill patient. This includes reviewing records and imaging, discussing care with other providers, documenting in the chart, and time on the unit spent directly managing or re-evaluating the patient. Time documentation must be explicit ("I spent 75 minutes in critical care activities for this patient") — not implied from note timestamps.
The ventilator management trap: 94002/94003 cannot be billed on the same day as critical care (99291/99292) unless the ventilator management constitutes a separately identifiable service. In most ICU scenarios where the pulmonologist is the attending, critical care time encompasses ventilator decisions — making ventilator management codes unbillable. But when a separate pulmonologist manages the ventilator while another physician (hospitalist, surgeon) provides critical care services, ventilator management is separately reportable. Manual billing teams either miss ventilator management entirely or bill it inappropriately alongside critical care, generating audit exposure.
What AI agents do: AI analyzes critical care documentation for time specificity — flagging notes that lack explicit time statements, identifying documentation that supports additional 99292 units, and calculating total billable critical care time across the day's encounters. AI enforces the critical care vs ventilator management mutual exclusivity rule when the same physician provides both services, identifies scenarios where separate provider ventilator management is reportable, validates that intubation (31500) is separately billed when performed, and ensures that bundled procedures (central line placement, chest tube insertion, ABG interpretation) are not double-billed alongside critical care time. For practices with 500–2,000 critical care encounters annually, documentation optimization and coding accuracy recovers $30K–$80K.
Sleep Medicine: The Overnight Revenue Stream That Leaks Through Technical Billing
Many pulmonology practices operate sleep labs — generating overnight revenue from polysomnography studies that carry their own coding complexity, split-night rules, and professional/technical component billing requirements.
Sleep Study Codes
- 95810 — Polysomnography, attended, ≥6 hours (diagnostic, without CPAP)
- 95811 — Polysomnography, attended, ≥6 hours, with CPAP titration
- 95805 — Multiple Sleep Latency Test (MSLT) or Maintenance of Wakefulness Test (MWT)
- 95800 — Home sleep apnea testing (HSAT), unattended, type 2 or type 3
- 95801 — Home sleep apnea testing, unattended, type 4 (fewer channels)
The split-night rule creates the primary billing complexity. When a diagnostic polysomnography (95810) demonstrates an AHI ≥40 (or ≥20 with significant desaturation) in the first 2 hours, the technologist can initiate CPAP titration in the same night — converting the study from 95810 to 95811. But if the split occurs too early (insufficient diagnostic data) or the titration portion doesn't meet minimum duration requirements, the study may not qualify for 95811 billing and should remain a 95810 with a follow-up titration study. Manual billing teams either always bill 95811 for split-night studies (risking denials when split-night criteria aren't met) or always bill 95810 (missing the higher reimbursement when criteria are met).
The professional/technical split adds another layer. Practices that own the sleep lab bill the global code (both professional and technical components). Practices that use an independent sleep lab for technical services bill only the -26 professional component. And practices that provide technical services for outside-reading physicians bill only the -TC technical component. A single practice may have all three arrangements across different payers — and billing the wrong component modifier generates denials or, worse, results in payment for the wrong component at the wrong rate.
What AI agents do: AI validates split-night criteria against the polysomnography report — checking diagnostic AHI threshold, minimum diagnostic recording time, and CPAP titration duration before selecting 95810 vs 95811. AI applies the correct professional/technical modifier based on the practice's ownership arrangement per study per payer, captures MSLT/MWT (95805) following a diagnostic night when narcolepsy or hypersomnolence evaluation is documented, and tracks HSAT (95800/95801) device deployment and return for practices using home testing programs. For practices running 500–1,500 sleep studies annually, correct code selection and modifier application recovers $25K–$60K.
Thoracentesis and Pleural Procedures: The Charge Capture That Disappears in Hospital Settings
Pulmonologists perform thoracentesis and pleural procedures across office, hospital, and interventional radiology suite settings — each with different coding, modifier, and place-of-service billing requirements.
- 32554 — Thoracentesis, needle or catheter, without imaging guidance
- 32555 — Thoracentesis, needle or catheter, with imaging guidance
- 32556 — Pleural drainage, percutaneous, with insertion of indwelling catheter (PleurX)
- 32557 — Pleural drainage with insertion of indwelling catheter and imaging guidance
- 32551 — Tube thoracostomy (chest tube), without imaging
- 32552 — Tube thoracostomy removal
The most common charge capture failure: a pulmonologist performs a bedside ultrasound-guided thoracentesis in the hospital. The procedure is documented in the progress note, but the charge is never submitted because the billing team doesn't capture hospital-based procedures separately from the daily E/M — assuming the procedure is "included" in the hospital visit. It isn't. Thoracentesis with imaging guidance (32555) is separately reportable from the E/M with modifier -25, and the ultrasound guidance is included in the code (no separate 76942). For a practice performing 200–600 thoracenteses annually, missed procedure charges cost $15K–$40K.
What AI agents do: AI scans procedure documentation across all encounter settings — office, hospital inpatient, ED — and captures thoracentesis and pleural procedure codes regardless of where they were performed. AI selects the correct code based on imaging guidance documentation (32554 vs 32555, 32556 vs 32557), applies place-of-service modifiers, pairs the procedure with the appropriate E/M when a separate evaluation supports modifier -25, and tracks indwelling pleural catheter (PleurX) management visits for ongoing drainage.
Q4 2026: Respiratory Season Meets Revenue Cycle Pressure
Three forces are converging on pulmonology billing this quarter:
- Respiratory season volume surge: Influenza, RSV, COVID-19, and COPD exacerbation season drives a 25–40% increase in pulmonology encounters from October through February. Emergency department consultations, hospital admissions, critical care encounters, and follow-up PFTs all spike simultaneously — overwhelming billing teams already managing complex baseline workflows.
- Medicare Advantage AEP (Oct 15–Dec 7): When COPD and asthma patients switch MA plans mid-treatment, every active biologic prior authorization and CPAP supply authorization expires. For practices managing 100+ patients on omalizumab, mepolizumab, or dupilumab, plan changes void the biologic authorization and can interrupt a treatment that took months of step therapy documentation to initiate. AI batch re-verification detects plan changes and initiates emergency PA re-authorization before the next scheduled biologic dose.
- Deductible-met elective procedures: Patients who have met their annual deductible accelerate bronchoscopy procedures, sleep studies, and PFT workups they deferred earlier in the year. This Q4 volume surge of 20–35% adds procedure-heavy encounters on top of the respiratory illness volume — creating a billing backlog that pushes claims past timely filing deadlines.
AI agents eliminate the seasonal staffing crunch. The same system that codes PFTs also validates bronchoscopy hierarchies, manages biologics buy-and-bill, captures critical care documentation, and bills sleep studies — deployed in 3–5 weeks, integrated with the practice's existing EHR and PFT lab systems, and running continuously without turnover, training gaps, or coverage vacations.